Schraut W H, Abraham V S, Lee K K
Surgery. 1986 Feb;99(2):193-8.
The potential metabolic and technical consequences of systemic (portacaval anastomosis [PC-A]) as opposed to portal venous drainage (portaportal anastomosis [PP-A]) of orthotopic small bowel isografts was evaluated in a rat model. Rats with portacaval (PC) shunts were studied for comparison. During the study period of 6 months, rats with small bowel grafts (PP-A or PC-A) gained weight at rates equal to that of normal age-matched rats (+40% of the preoperative weight) whereas rats with PC shunts lost 20% of their weight. At autopsy 6 months after operation, rats with PC shunts had significant liver atrophy (2.0% of total body weight) in comparison with rats with orthotopic isografts. Moderate liver atrophy was detected in rats with grafts and PC-A in comparison with those with PP-A (2.6% versus 2.8% of total body weight, statistically not significant). Serum ammonia levels were significantly elevated for PC shunts (560 +/- 148 micrograms/dl) and PC-A (140 +/- 22 micrograms/dl) when compared with PP-A (83 +/- 10 micrograms/dl). In terms of technical difficulties, both PC-A and PP-A could be achieved with the same success rate. Systemic venous drainage for small bowel grafts is followed by metabolic alterations that are similar, although much less pronounced, to those seen after a PC shunt. Thus our findings do not offer compelling reasons to prefer PP-A over PC-A. However, with longer follow-up and the use of hepatotoxic immunosuppressive drugs, these minimal alterations may progress and induce metabolic sequelae of clinical significance. Under these circumstances it would be advisable to use the physiologic portal drainage rather than systemic venous drainage in small bowel transplantation.
在大鼠模型中评估了原位小肠同种异体移植采用全身(门腔静脉吻合术[PC-A])而非门静脉引流(门门静脉吻合术[PP-A])可能产生的代谢和技术后果。对伴有门腔静脉(PC)分流的大鼠进行了研究以作比较。在6个月的研究期间,接受小肠移植的大鼠(PP-A或PC-A)体重增加速度与年龄匹配的正常大鼠相同(达到术前体重的+40%),而伴有PC分流的大鼠体重减轻了20%。术后6个月尸检时,与接受原位同种异体移植的大鼠相比,伴有PC分流的大鼠出现了明显的肝脏萎缩(占总体重的2.0%)。与接受PP-A的大鼠相比,接受移植且采用PC-A的大鼠检测到中度肝脏萎缩(分别为总体重的2.6%和2.8%,无统计学显著差异)。与PP-A(83±10微克/分升)相比,PC分流组(560±148微克/分升)和PC-A组(140±22微克/分升)的血清氨水平显著升高。在技术难度方面,PC-A和PP-A的成功率相同。小肠移植采用全身静脉引流会导致代谢改变,这些改变与PC分流后所见的改变相似,尽管程度要轻得多。因此,我们的研究结果没有提供令人信服的理由表明PP-A优于PC-A。然而,随着随访时间延长以及使用具有肝毒性的免疫抑制药物,这些微小改变可能会进展并引发具有临床意义的代谢后遗症。在这种情况下,小肠移植采用生理性门静脉引流而非全身静脉引流更为可取。